{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2u","columns":[{"gene":"","key":"population-7198640535965dcce0d8","label":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","mondoId":"MONDO:0014474","onsetQualifier":null,"originColumnKey":"MONDO:0014474/OMIM:616052","originalViews":[{"key":"MONDO:0014474/OMIM:616052","label":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","scopeLabel":"OMIM:616052","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["1a2fcf3640e2cd5a9b7de9fb7eb52aee3762f4738a3b87a1269b630f0cc2a84b","3f086883be6b0e1152c556c52ca722a4802a22edbfb785cf3cce55419bcb2c2e","49b698f3123a02d174b9c27880054906c1e7d2e3b652dae5e485aabf98cb1f4f","6c3db61d978677ef7ddb43e2301b4fb71f952c02c47926bf28c18f59402a254c","7b62a7286ff6d6ae65c8639ee9fd125ab5ac8e040dc2d624587a6533f1873fd7","a3dd9e2252e2b2d8ff48e3bf1583590ffa332d45b08e5ef0b41caa9bc1a90217","ce8edde227f5abb6106c3add2563c40f49d7b812a5e0ea2ff8f79b3eb28f9e0f","d9b3aa68850bf563bb490cdfd9cef5d2eaedeec1bc63f50d54b22fac5de77094","dd422a497deb5d0d60ae5655fc1750776ee58d87e1356dfc8bb964d2925bfca8","ef8614baa9839fa7e85e901d369886893fd215b1b95555350d5b118146c29f34"],"recordQualifiers":{},"scopeLabel":"OMIM:616052","sourceIds":["OMIM:616052"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-f1ef1449807bdc838ec9","label":"ISPD-related limb-girdle muscular dystrophy R20","mondoId":"MONDO:0014474","onsetQualifier":null,"originColumnKey":"MONDO:0014474/ORPHA:352479","originalViews":[{"key":"MONDO:0014474/ORPHA:352479","label":"ISPD-related limb-girdle muscular dystrophy R20","scopeLabel":"ORPHA:352479","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["01e573cb4fc26f883701c0dd6592cc1e4dae8d33fca487b951ee8c1323a6a74e","10ab40a9fb6cc6a1303410ef03a3eb056b180e41ac29b6c97d440897de078d70","247396310233b8480a36b2deabfdedbf1bc4331d6e123f66b2546eefb9b7340f","4c79649df763a8b328ff17fb65db5be833c6d3d6b02b497706f9e80b9c08e933","5587c504db1312725772be0fc8abb635dc5e584308a0bd0e896592092cd68839","5c837d7d3773006d9e82e38e0c7844cc634b0f2d0a7611e0b22c5bf9a95eadbf","77e1680c356bcf05108566486c42d7d74520accf74ea4edb1a98486ec5ebf78a","961d7f6815442eaf4c71e4328c51931ce33e732f54ff61e26df77e553d9af996","9a0df74d8f9378ceda1230b658dca83e521ec577625ad82a6ed80adbc9dce0a2","b56b141c69c4211809bb5209bcb60619a5aedd0eca7992effa0d814b18b21035","bbc7b97eef0ac1387b63b63af47f6040bc4454250b78c6799c4c924ff232895c","d7295649c8e34552f880e47f65729b27732023ac7608ea4e8440c6a7dc9cdcd4","df00753c96efae497762cf03ba4d17c0c0486c6d1194f97511386c296a7b6fe9","df0c64546dc0ea30479fc4caf23952906b189e08263a087beaff0c1e2b7ff63a","e083bf75e0a5a89f1d438beff5cdb54881d653a53d07e1d25b14213b5cc31963","f341b345b90678fda7b4ec16fa4eff912b4dba873f52d1f825ba6dca67549604"],"recordQualifiers":{},"scopeLabel":"ORPHA:352479","sourceIds":["ORPHA:352479"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7198640535965dcce0d8","population-f1ef1449807bdc838ec9"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011446","HP:0001626","HP:0000478","HP:0008981","HP:0003707","HP:0003236","HP:0008305"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"orphanet":16,"published":10}},"features":[{"hpoId":"HP:0011446","label":"Abnormality of mental function","primary":true},{"hpoId":"HP:0001626","label":"Abnormality of the cardiovascular system","primary":true},{"hpoId":"HP:0000478","label":"Abnormality of the eye","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":true},{"hpoId":"HP:0003707","label":"Calf muscle pseudohypertrophy","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0008305","label":"Exercise-induced myoglobinuria","primary":true},{"hpoId":"HP:0030234","label":"Highly elevated creatine kinase","primary":false},{"hpoId":"HP:0030046","label":"Hypoglycosylation of alpha-dystroglycan","primary":false},{"hpoId":"HP:0003325","label":"Limb-girdle muscle weakness","primary":false},{"hpoId":"HP:0006785","label":"Limb-girdle muscular dystrophy","primary":false},{"hpoId":"HP:0002505","label":"Loss of ambulation","primary":false},{"hpoId":"HP:0007340","label":"Lower limb muscle weakness","primary":false},{"hpoId":"HP:0000158","label":"Macroglossia","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0008994","label":"Proximal lower limb muscle weakness","primary":false},{"hpoId":"HP:0008997","label":"Proximal upper limb muscle weakness","primary":false},{"hpoId":"HP:0032341","label":"Reduced forced vital capacity","primary":false},{"hpoId":"HP:0002792","label":"Reduced vital capacity","primary":false},{"hpoId":"HP:0003691","label":"Scapular winging","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false}],"ledeHtml":"A rare subtype of autosomal recessive limb-girdle muscular dystrophy disorder characterized by infantile to childhood-onset of slowly progressive, principally proximal, shoulder and/or pelvic-girdle muscular weakness that typically presents with positive Gowers&#x27; sign and is associated with elevated creatine kinase levels, hyporeflexia, joint and achilles tendon contractures, and muscle hypertrophy, usually of the thighs, calves and/or tongue. Other highly variable features include cerebellar, cardiac and ocular abnormalities.","mondoId":"MONDO:0014474","node":{"canonicalSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2u","comparisons":[{"documentSha256":"b619b9112f890fea534512fcba46c6c78499d2ce6254a6a5376c6d6c243c4b51","key":"legacy-autosomal-recessive-limb-girdle-muscular-dystrophy-type-2u","kind":"legacy","label":"autosomal recessive limb-girdle muscular dystrophy type 2U","memberIds":["MONDO:0014474"],"mondoId":"MONDO:0014474","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autosomal-recessive-limb-girdle-muscular-dystrophy-type-2u.b619b9112f890fea534512fcba46c6c78499d2ce6254a6a5376c6d6c243c4b51.json"},{"documentSha256":"44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659","key":"expanded-limb-girdle-muscular-dystrophy","kind":"expanded","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009181","MONDO:0009675","MONDO:0009676","MONDO:0009677","MONDO:0009681","MONDO:0009683","MONDO:0011028","MONDO:0011170","MONDO:0011423","MONDO:0011787","MONDO:0011968","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012215","MONDO:0012248","MONDO:0012652","MONDO:0012699","MONDO:0013161","MONDO:0013162","MONDO:0013297","MONDO:0013390","MONDO:0013440","MONDO:0014142","MONDO:0014144","MONDO:0014474","MONDO:0014489","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0015151","MONDO:0015152","MONDO:0016971","MONDO:0018098","MONDO:0021018","MONDO:0021569","MONDO:0024530","MONDO:0029133","MONDO:0029135","MONDO:0029136","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-44b063290da75047b19d.44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659.json"},{"documentSha256":"9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8","key":"expanded-muscular-dystrophy-dystroglycanopathy","kind":"expanded","label":"muscular dystrophy-dystroglycanopathy","memberIds":["MONDO:0000171","MONDO:0000172","MONDO:0000173","MONDO:0009364","MONDO:0009667","MONDO:0009678","MONDO:0011688","MONDO:0011787","MONDO:0012138","MONDO:0012248","MONDO:0012699","MONDO:0013049","MONDO:0013154","MONDO:0013155","MONDO:0013156","MONDO:0013157","MONDO:0013158","MONDO:0013159","MONDO:0013160","MONDO:0013161","MONDO:0013162","MONDO:0013440","MONDO:0013835","MONDO:0013904","MONDO:0014022","MONDO:0014023","MONDO:0014071","MONDO:0014101","MONDO:0014120","MONDO:0014140","MONDO:0014141","MONDO:0014142","MONDO:0014474","MONDO:0014489","MONDO:0014683","MONDO:0018276","MONDO:0018278","MONDO:0018280","MONDO:0029135","MONDO:0033556"],"mondoId":"MONDO:0018276","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-9e938372c5990a8aec98.9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal recessive limb-girdle muscular dystrophy type 2U","originalSourceId":"ORPHA:352479","paragraphs":["A rare subtype of autosomal recessive limb-girdle muscular dystrophy disorder characterized by infantile to childhood-onset of slowly progressive, principally proximal, shoulder and/or pelvic-girdle muscular weakness that typically presents with positive Gowers' sign and is associated with elevated creatine kinase levels, hyporeflexia, joint and achilles tendon contractures, and muscle hypertrophy, usually of the thighs, calves and/or tongue. Other highly variable features include cerebellar, cardiac and ocular abnormalities."],"rawAttribution":"MONDO:0014474","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:35Z","upstream":"ORPHA:352479","url":"https://rarediseases.info.nih.gov/diseases/17519"},"ownColumnKeys":["population-7198640535965dcce0d8","population-f1ef1449807bdc838ec9"],"publication":"published","relationships":[{"kind":"parent","label":"muscular dystrophy-dystroglycanopathy, type C","mondoId":"MONDO:0000173","slug":null},{"kind":"parent","label":"autosomal recessive limb-girdle muscular dystrophy","mondoId":"MONDO:0015152","slug":null},{"kind":"parent","label":"myopathy caused by variation in CRPPA","mondoId":"MONDO:0100530","slug":"myopathy-caused-by-variation-in-crppa"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"01e573cb4fc26f883701c0dd6592cc1e4dae8d33fca487b951ee8c1323a6a74e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002505","is_excluded":false,"label":"Loss of ambulation","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"10ab40a9fb6cc6a1303410ef03a3eb056b180e41ac29b6c97d440897de078d70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008305","is_excluded":false,"label":"Exercise-induced myoglobinuria","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1a2fcf3640e2cd5a9b7de9fb7eb52aee3762f4738a3b87a1269b630f0cc2a84b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"247396310233b8480a36b2deabfdedbf1bc4331d6e123f66b2546eefb9b7340f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001626","is_excluded":false,"label":"Abnormality of the cardiovascular system","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3f086883be6b0e1152c556c52ca722a4802a22edbfb785cf3cce55419bcb2c2e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0007340","is_excluded":false,"label":"Lower limb muscle weakness","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"49b698f3123a02d174b9c27880054906c1e7d2e3b652dae5e485aabf98cb1f4f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000158","is_excluded":false,"label":"Macroglossia","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4c79649df763a8b328ff17fb65db5be833c6d3d6b02b497706f9e80b9c08e933","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008994","is_excluded":false,"label":"Proximal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5587c504db1312725772be0fc8abb635dc5e584308a0bd0e896592092cd68839","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008997","is_excluded":false,"label":"Proximal upper limb muscle weakness","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c837d7d3773006d9e82e38e0c7844cc634b0f2d0a7611e0b22c5bf9a95eadbf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030046","is_excluded":false,"label":"Hypoglycosylation of alpha-dystroglycan","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"6c3db61d978677ef7ddb43e2301b4fb71f952c02c47926bf28c18f59402a254c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"77e1680c356bcf05108566486c42d7d74520accf74ea4edb1a98486ec5ebf78a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030234","is_excluded":false,"label":"Highly elevated creatine kinase","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7b62a7286ff6d6ae65c8639ee9fd125ab5ac8e040dc2d624587a6533f1873fd7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0030046","is_excluded":false,"label":"Hypoglycosylation of alpha-dystroglycan","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"961d7f6815442eaf4c71e4328c51931ce33e732f54ff61e26df77e553d9af996","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003707","is_excluded":false,"label":"Calf muscle pseudohypertrophy","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a0df74d8f9378ceda1230b658dca83e521ec577625ad82a6ed80adbc9dce0a2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a3dd9e2252e2b2d8ff48e3bf1583590ffa332d45b08e5ef0b41caa9bc1a90217","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0032341","is_excluded":false,"label":"Reduced forced vital capacity","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b56b141c69c4211809bb5209bcb60619a5aedd0eca7992effa0d814b18b21035","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002792","is_excluded":false,"label":"Reduced vital capacity","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bbc7b97eef0ac1387b63b63af47f6040bc4454250b78c6799c4c924ff232895c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ce8edde227f5abb6106c3add2563c40f49d7b812a5e0ea2ff8f79b3eb28f9e0f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d7295649c8e34552f880e47f65729b27732023ac7608ea4e8440c6a7dc9cdcd4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000478","is_excluded":false,"label":"Abnormality of the eye","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d9b3aa68850bf563bb490cdfd9cef5d2eaedeec1bc63f50d54b22fac5de77094","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0006785","is_excluded":false,"label":"Limb-girdle muscular dystrophy","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dd422a497deb5d0d60ae5655fc1750776ee58d87e1356dfc8bb964d2925bfca8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0002505","is_excluded":false,"label":"Loss of ambulation","onset_id":"HP:0025710","reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"df00753c96efae497762cf03ba4d17c0c0486c6d1194f97511386c296a7b6fe9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011446","is_excluded":false,"label":"Abnormality of mental function","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df0c64546dc0ea30479fc4caf23952906b189e08263a087beaff0c1e2b7ff63a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000158","is_excluded":false,"label":"Macroglossia","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e083bf75e0a5a89f1d438beff5cdb54881d653a53d07e1d25b14213b5cc31963","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ef8614baa9839fa7e85e901d369886893fd215b1b95555350d5b118146c29f34","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616052","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:23390185","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f341b345b90678fda7b4ec16fa4eff912b4dba873f52d1f825ba6dca67549604","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352479","disease_name":"ISPD-related limb-girdle muscular dystrophy R20","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003325","is_excluded":false,"label":"Limb-girdle muscle weakness","onset_id":null,"reference":"ORPHA:352479","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17519\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014474\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:352479</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare subtype of autosomal recessive limb-girdle muscular dystrophy disorder characterized by infantile to childhood-onset of slowly progressive, principally proximal, shoulder and/or pelvic-girdle muscular weakness that typically presents with positive Gowers&#x27; sign and is associated with elevated creatine kinase levels, hyporeflexia, joint and achilles tendon contractures, and muscle hypertrophy, usually of the thighs, calves and/or tongue. Other highly variable features include cerebellar, cardiac and ocular abnormalities.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17519\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2u","sourceDocuments":[{"name":"GARD: Autosomal recessive limb-girdle muscular dystrophy type 2U","reviewed":null,"source_release":"2026-10-21T17:02:35Z","url":"https://rarediseases.info.nih.gov/diseases/17519"},{"name":"MONDO: autosomal recessive limb-girdle muscular dystrophy type 2U","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014474"}],"sourceNote":"","synonyms":["autosomal recessive limb-girdle muscular dystrophy caused by mutation in ISPD","ISPD autosomal recessive limb-girdle muscular dystrophy","LGMD2U","MDDGC7","muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7"],"takeawayHtml":"","title":"autosomal recessive limb-girdle muscular dystrophy type 2U"},"schemaVersion":1}
